Pembrolizumab in a Patient With a Metastatic CASTLE Tumor of the Parotid.
Saved in:
| Title: | Pembrolizumab in a Patient With a Metastatic CASTLE Tumor of the Parotid. |
|---|---|
| Authors: | Lorenz L; Department of Internal Medicine, Hirslanden Klinik St. Anna, Lucerne, Switzerland., von Rappard J; Department of Internal Medicine, Hirslanden Klinik St. Anna, Lucerne, Switzerland., Arnold W; Department of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland., Mutter N; Department of Oncology, Hirslanden Klinik St. Anna, Lucerne, Switzerland., Schirp U; Institute of Radiology and Nuclear Medicine, Hirslanden Klinik St. Anna, Lucerne, Switzerland., Scherr A; Department of Pneumology, Hirslanden Klinik St. Anna, Lucerne, Switzerland., Jehle AW; Department of Internal Medicine, Hirslanden Klinik St. Anna, Lucerne, Switzerland.; Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland. |
| Source: | Frontiers in oncology [Front Oncol] 2019 Aug 14; Vol. 9, pp. 734. Date of Electronic Publication: 2019 Aug 14 (Print Publication: 2019). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2019.00734 |
